Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends
2022
Hardeep Singh Tuli | Prangya Rath | Abhishek Chauhan | Anuj Ranjan | Seema Ramniwas | Katrin Sak | Diwakar Aggarwal | Manoj Kumar | Kuldeep Dhama | E Hui Clarissa Lee | Kenneth Chun-Yong Yap | Sharah Mae Capinpin | Alan Prem Kumar
Cucurbitacins constitute a group of cucumber-derived dietary lipids, highly oxidized tetracyclic triterpenoids, with potential medical uses. These compounds are known to interact with a variety of recognized cellular targets to impede the growth of cancer cells. Accumulating evidence has suggested that inhibition of tumor cell growth via induction of apoptosis, cell-cycle arrest, anti-metastasis and anti-angiogenesis are major promising chemo-preventive actions of cucurbitacins. Cucurbitacins may be a potential choice for investigations of synergism with other drugs to reverse cancer cells’ treatment resistance. The detailed molecular mechanisms underlying these effects include interactions between cucurbitacins and numerous cellular targets (Bcl-2/Bax, caspases, STAT3, cyclins, NF-κB, COX-2, MMP-9, VEGF/R, etc.) as well as control of a variety of intracellular signal transduction pathways. The current study is focused on the efforts undertaken to find possible molecular targets for cucurbitacins in suppressing diverse malignant processes. The review is distinctive since it presents all potential molecular targets of cucurbitacins in cancer on one common podium.
显示更多 [+] 显示较少 [-]